Participating Faculty for Evolving Knowledge of the Unmet Needs in Dry Eye Disease

March 16, 2021
Supplements and Featured Publications, Evolving Knowledge of the Unmet Needs in Dry Eye Disease, Volume 27, Issue 2

Faculty

Jeffrey D. Dunn, PharmD, MBA
Vice President (previously)
Clinical Strategy and Programs and Industry Relations
Magellan Rx
Salt Lake City, Utah

Paul M. Karpecki, OD
Director
Cornea and External Disease
Kentucky Eye Institute
Lexington, Kentucky

Associate Professor
Kentucky College of Optometry
University of Pikeville
Pikeville, Kentucky

Mary Elizabeth Meske, PharmD, RPh
Manager, Clinical Pharmacy
Senior Clinical Account Executive
National Health Plan/Pharmacy Benefit Manager

Deborah Reissman, PharmD
Managed Care Pharmacy Consultant
San Marcos, California

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:

Paul M. Karpecki, OD

CONSULTANT OR PAID ADVISORY BOARD MEMBER:

AbbVie Inc; Bausch + Lomb Inc; Kala Pharmaceuticals; Novartis; Oyster Point Pharma, Inc; Sun Pharmaceutical Industries Ltd

LECTURE FEES:

Bausch + Lomb Inc, Dompé, Eyevance Pharmaceuticals LLC, Kala Pharmaceuticals, Mallinckrodt Pharmaceuticals, Neurolens, Osmotica Pharmaceuticals, Sun Pharmaceutical Industries Ltd

Deborah Reissman, PharmD

CONSULTANT OR PAID ADVISORY BOARD MEMBER:

Market research interviews on dry eye disease (blinded)

HONORARIA:

Market research interviews on dry eye disease (blinded)

Jeffrey D. Dunn, PharmD, MBA, and Mary Elizabeth Meske, PharmD, RPh, report no relationships or financial interests with any entity that would pose a conflict of interest with the subject matter of this supplement.